Cell-Wall glycolipid mutations and their effects on virulence of E. Faecalis in a rat model of infective endocarditis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Haller, Christoph ^a   Berthold, Martin ^b   Wobser, Dominique ^b   Kropec, Andrea ^b   Lauriola, Marinella ^b   Schlensak, Christian ^a   Huebner, Johannes ^c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID; BACTERIAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; BACTERIAL COUNT; BACTERIAL ENDOCARDITIS; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BIOFILM; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; MUTATION; NONHUMAN; PATHOGENESIS; RAT; STRAIN DIFFERENCE; VEGETATION; ANIMAL; CELL WALL; DISEASE MODEL; FEMALE; GENETICS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

ANIMALS; BACTERIAL PROTEINS; CELL WALL; DISEASE MODELS, ANIMAL; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECALIS; FEMALE; GLYCOLIPIDS; MUTATION; RATS; VIRULENCE;

EID: 84898651733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091863     Document Type: Article

References (23)

1. Boucher HW, Corey GR (2008) Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46 Suppl 5: S344-S349. doi:10.1086/533590. (Pubitemid 351717321)
2. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcareassociated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29: 996-1011. doi:10.1086/591861.
3. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, et al. (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13.
4. Wang A, Athan E, Pappas PA, Fowler VG, Olaison L, et al. (2007) Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297: 1354-1361. doi:10.1001/jama.297.12.1354. (Pubitemid 46513236)
5. Baldassarri L, Cecchini R, Bertuccini L, Ammendolia MG, Iosi F, et al. (2001) Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med Microbiol Immunol 190: 113-120. (Pubitemid 33141332)
6. Joyanes P, Pascual A, Martínez-Martínez L, Hevia A, Perea EJ (1999) In vitro adherence of Enterococcus faecalis and Enterococcus faecium to plastic biomaterials. Clin Microbiol Infect 5: 382-386. (Pubitemid 29312619)
7. Joyanes P, Pascual A, Martínez-Martínez L, Hevia A, Perea EJ (2000) In vitro adherence of Enterococcus faecalis and Enterococcus faecium to urinary catheters. Eur J Clin Microbiol Infect Dis 19: 124-127. (Pubitemid 30139400)
8. Su SH, Eaton JW, Venezia RA, Tang L (1998) Interactions of vancomycin resistant enterococci with biomaterial surfaces. ASAIO J 44: 770-775. (Pubitemid 28514293)
9. Toledo-Arana A, Valle J, Solano C, Arrizubieta MJ, Cucarella C, et al. (2001) The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol 67: 4538-4545. (Pubitemid 33646082)
10. Paganelli F, Willems R (2011) Trends in Microbiology-Optimizing future treatment of enterococcal infections: attacking the biofilm? Trends in Microbiology.
11. Theilacker C, Sava I, Sanchez-Carballo P, Bao Y, Kropec A, et al. (2011) Deletion of the glycosyltransferase bgsB of Enterococcus faecalis leads to a complete loss of glycolipids from the cell membrane and to impaired biofilm formation. BMC Microbiol 11: 67. doi:10.1186/1471-2180-11-67.
12. Heikens E, Singh K, Jacques-Palaz K (2011) Contribution of the enterococcal surface protein Esp to pathogenesis of Enterococcus faecium endocarditis. Microbes.
13. Nallapareddy SR, Singh KV, Sillanpäa J, Zhao M, Murray BE (2011) Relative Contributions of Ebp Pili and the Collagen Adhesin Ace to Host Extracellular Matrix Protein Adherence and Experimental Urinary Tract Infection by Enterococcus faecalis OG1RF.
14. Theilacker C, Sanchez-Carballo P, Toma I, Fabretti F, Sava I, et al. (2009) Glycolipids are involved in biofilm accumulation and prolonged bacteraemia in Enterococcus faecalis. Molecular Microbiology 71: 1055-1069. doi:10.1111/j.1365-2958.2009.06587.x.
15. Sava IG, Zhang F, Toma I, Theilacker C, Li B, et al. (2009) Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells. J Biol Chem 284: 18194-18201. doi:10.1074/jbc. M901460200.
16. Huebner J, Wang Y, Krueger WA, Madoff LC, Martirosian G, et al. (1999) Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infection and Immunity 67: 1213-1219. (Pubitemid 29108497)
17. Huebner J, Quaas A, Krueger WA, Goldmann DA, Pier GB (2000) Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and-resistant enterococci. Infection and Immunity 68: 4631-4636. (Pubitemid 30497734)
18. Durack DT, Beeson PB (1972) Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol 53: 44-49.
19. Santoro J, Levison ME (1978) Rat model of experimental endocarditis. Infection and Immunity 19: 915-918.
20. Arias CA, Murray BE (2012) The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Micro 10: 266-278. doi:10.1038/nrmicro2761.
21. Sandoe JAT, Witherden IR, Cove JH, Heritage J, Wilcox MH (2003) Correlation between enterococcal biofilm formation in vitro and medicaldevice-related infection potential in vivo. J Med Microbiol 52: 547-550. (Pubitemid 36871891)
22. Guo Q-Y, Xiao G, Li R, Guan S-M, Zhu X-L, et al. (2006) Treatment of Streptococcus mutans with antisense oligodeoxyribonucleotides to gtfB mRNA inhibits GtfB expression and function. FEMS Microbiol Lett 264: 8-14. doi:10.1111/j.1574-6968.2006.00378.x. (Pubitemid 44511048)
23. Rasko DA, Sperandio V (2010) Anti-virulence strategies to combat bacteriamediated disease. Nat Rev Drug Discov 9: 117-128. doi:10.1038/nrd3013.